Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Risk: Results From the PARTNER 2 Trial

BACKGROUND:In patients with severe aortic stenosis (AS) at intermediate surgical risk, treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR) results in similar rates of death or stroke at 2 years. Whether TAVR is cost-effective compared with SAVR fo...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Circulation (New York, N.Y.) N.Y.), 2019-02, Vol.139 (7), p.877-888
Hauptverfasser:	Baron, Suzanne J, Wang, Kaijun, House, John A, Magnuson, Elizabeth A, Reynolds, Matthew R, Makkar, Raj, Herrmann, Howard C, Kodali, Susheel, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars, Mack, Michael J, Brown, David L, Russo, Mark J, Smith, Craig R, Webb, John, Miller, Craig, Leon, Martin B, Cohen, David J
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!